Gene silencing works with the body to turn down the volume on harmful genes at the source. Check out our gene silencing eBook to learn more about this ground-breaking field of research: https://t.co/piwYAN8U1T

Today's Q3 2025 update includes our latest financial results and business developments. Read more: https://t.co/9g49YqyG98 #SilenceIsGOLDen $SLN

We were pleased to attend the 8th Annual Meeting of the International Academy for Clinical Hematology (IACH), which brought together global experts to discuss the latest in MPN research and innovation. Learn more about our work advancing siRNA-based therapies in hematology:

Enrollment is now complete in our Phase 2 clinical trial of our first-in-class siRNA for people living with polycythemia vera (PV). The study enrolled ahead of schedule in just 11 months, underscoring strong interest in advancing potential new treatment options. Topline results

Polycythemia vera (PV) is a rare blood cancer that causes the body to make too many red blood cells. Explore our PV eBook to learn more. https://t.co/bMxz05rSu6

In this Q&A with @statnews, Craig Tooman, our president and CEO, discusses Silence’s foundation, the science behind our mRNAi GOLD™ platform, and our progress in developing RNA-based treatments for polycythemia vera (PV) and high Lp(a). Read more:

It’s Health Literacy Month and we’re committed to making complex science easier to understand. From music and art to video and e-books, our resources help bring RNA science to life. Learn more: https://t.co/313XZbHdu6

We were proud to join the global MPN community at the 10th MPN Horizons Conference, hosted by @GMPNAN, in Marrakesh, Morocco. A great opportunity to connect with patient advocates, clinicians, and partners working to advance care and understanding for those living with

In a recent interview with OncLive, Marina Kremyanskaya, MD, PhD, discussed our investigational siRNA therapy in development for people living with polycythemia vera (PV). Read more: https://t.co/E6AncjhTfm #SilenceIsGOLDen

Raising awareness of polycythemia vera (PV) can start with something as simple as coloring a page. For MPN Awareness Month, our employees picked up crayons, markers, and pencils to bring our “Share Your Colors” PV coloring book to life, a small but meaningful way to raise

Silence was proud to be part of the 11th Annual Women and MPN Conference hosted by @mpnadvocacy. Our Senior Director, Medical Science Liaison, Joe Loiars, connected with colleagues and leaders in the MPN space, including Dr. Jennifer Vaughn, who shared insights on

Heart health starts with awareness. On #WorldHeartDay, take a moment to learn about high Lp(a), an inherited risk factor for cardiovascular disease. Knowing your levels could make a difference. Learn more: https://t.co/WdqngypWXg

Understanding the patient voice is essential in shaping the future of care for people with myeloproliferative neoplasms (MPNs). In a recent webinar hosted by @gmpnsf, our Senior Clinical Science Director Alberto Martinez joined patients, physicians, and industry to explore what

For MPN Awareness Month, our colleagues across the UK, US, and Germany came together to learn more about the impact of myeloproliferative neoplasms (MPNs). We were grateful to hear from Nona Baker, co-chair of @MPNVoice, who shared her personal perspective living with

During #MPNAwarenessMonth, we joined @MPNAdvocacy for a webinar on living with MPNs. Proud to support advocacy partners bringing patient & specialist voices together. Watch the replay: https://t.co/ZoqDP4Mc9l #SilenceIsGOLDen

Living with polycythemia vera (PV)? Small lifestyle choices can make a big impact. For more tips on managing PV, visit https://t.co/hNuRyqugI7. #MPNAwarenessMonth

We’re honored to be recognized as one of the 2025 UK’s Best Workplaces in BioPharma by @GPTW_UK! Thank you to our incredible team for making Silence a place where science and community thrive. https://t.co/Zx0A56wfvr #GreatPlaceToWork #BioPharma

Today is MPN Awareness Day and Semptember marks the start of MPN Awareness Month, a time to spotlight the unique challenges of people living with myeloproliferative neoplasms, including polycythemia vera (PV). At Silence, we believe education is empowering. That’s why we created

Today, we pause to remember the lives lost on September 11 and honor the courage of the first responders, survivors, and families forever impacted. With deep respect from our Silence team in Hoboken and around the world.

Today at 12:00pm ET, we will participate in a Fireside Chat at the H.C. Wainwright Global Investment Conference in New York. For the live or archived replay of the presentation, visit https://t.co/JFyMsoG4po. #SilenceIsGOLDen